← Back to Search

Non-Pharmacological Therapy

Cognitive training + active-tDCS for SARS-CoV-2 Infection

N/A
Waitlist Available
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and post-test assessment, 4 weeks
Awards & highlights

Study Summary

This trial looks at how tDCS and cognitive training tasks can improve cognitive impairment symptoms in people with long COVID. It will compare active and sham tDCS treatments.

Eligible Conditions
  • SARS-CoV-2 Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and post-test assessment, 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and post-test assessment, 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Placebos
Placebos

Side effects data

From 2012 Phase 3 trial • 60 Patients • NCT01649232
10%
headache
10%
headedness / dizziness
7%
fatigue or nausea
100%
80%
60%
40%
20%
0%
Study treatment Arm
Active tDCS
Controls

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Cognitive training + active-tDCSExperimental Treatment1 Intervention
Cognitive training + active-tDCS 4 times per week (20 minutes per session, each (~25cm²; current density = 0.08 mA/cm²); anode on left dorsolateral prefrontal cortex F3, cathode on right dorsolateral prefrontal cortex F4) for four weeks.
Group II: Cognitive training + sham-tDCSPlacebo Group1 Intervention
Cognitive training + sham-tDCS 4 times per week (20 minutes per session, each ~25cm²; current density = 0.08 mA/cm²); anode on left dorsolateral prefrontal cortex F3, cathode on right dorsolateral prefrontal cortex F4) for four weeks.

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,381 Previous Clinical Trials
1,588,775 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals still able to enroll in this trial?

"Clinicaltrials.gov reveals that the study, which was initially launched on January 1st 2023 and last edited in November 18th 2022, is no longer accepting participants. Alternatively, there are 931 other trials presently recruiting volunteers at this time."

Answered by AI

Might I be eligible to participate in this clinical experiment?

"For potential enrolment in this study, participants must have recently recovered from SARS-Cov-2 infection and be between 18 to 60 years of age. Approximately 60 individuals will receive an invitation for inclusion into the trial."

Answered by AI

Does this clinical trial accommodate patients beyond the age of seventy?

"This trial is recruiting participants whose age falls between 18 and 60 years old, adhering to the set criteria for eligibility."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
TDCS-potentiated Generalization of Cognitive Training in the Rehabilitation of Long COVID Symptoms
2023. "TDCS-potentiated Generalization of Cognitive Training in the Rehabilitation of Long COVID Symptoms". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05589272.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top